{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:10:56Z","timestamp":1771841456460,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Intrahepatic Cholangiocarcinoma Clinical Cohort Research Program, National Key Research on Precision Medicine of China","award":["2017YFC0908102"],"award-info":[{"award-number":["2017YFC0908102"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772507"],"award-info":[{"award-number":["81772507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Technological Innovation and Action Project of the Shanghai Science and Technology Commission","award":["15411950401"],"award-info":[{"award-number":["15411950401"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s12072-018-9881-y","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T09:47:50Z","timestamp":1530006470000},"page":"330-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4646-8998","authenticated-orcid":false,"given":"Seogsong","family":"Jeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guijuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Heng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Sha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"9881_CR1","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383:2168\u201379.","journal-title":"Lancet"},{"key":"9881_CR2","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1200\/JCO.2011.35.6519","volume":"29","author":"MC Jong de","year":"2011","unstructured":"de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29:3140\u20135.","journal-title":"J Clin Oncol"},{"key":"9881_CR3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s12885-017-3464-5","volume":"17","author":"S Jeong","year":"2017","unstructured":"Jeong S, Cheng Q, Huang L, et al. Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection. BMC Cancer. 2017;17:464.","journal-title":"BMC Cancer"},{"key":"9881_CR4","doi-asserted-by":"publisher","first-page":"6543423","DOI":"10.1155\/2017\/6543423","volume":"2017","author":"S Jeong","year":"2017","unstructured":"Jeong S, Gao L, Tong Y, et al. Prognostic impact of cirrhosis in patients with intrahepatic cholangiocarcinoma following hepatic resection. Can J Gastroenterol Hepatol. 2017;2017:6543423.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"9881_CR5","doi-asserted-by":"crossref","first-page":"17292","DOI":"10.18632\/oncotarget.14079","volume":"8","author":"S Jeong","year":"2017","unstructured":"Jeong S, Tong Y, Sha M, Gu J, Xia Q. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Oncotarget. 2017;8:17292\u2013300.","journal-title":"Oncotarget"},{"key":"9881_CR6","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1245\/s10434-016-5751-9","volume":"24","author":"Q Wang","year":"2017","unstructured":"Wang Q, Li J, Lei Z, et al. Prognosis of intrahepatic cholangiocarcinomas with HBV infection is better than those with hepatolithiasis after R0 liver resection: a propensity score matching analysis. Ann Surg Oncol. 2017;24:1579\u201387.","journal-title":"Ann Surg Oncol"},{"key":"9881_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/ans.13753","volume":"88","author":"CS Ahn","year":"2018","unstructured":"Ahn CS, Hwang S, Lee YJ, et al. Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma. ANZ J Surg. 2018;88:212\u20137.","journal-title":"ANZ J Surg"},{"key":"9881_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.clinre.2016.04.001","volume":"40","author":"LY Tao","year":"2016","unstructured":"Tao LY, He XD, Xiu DR. Hepatitis B virus is associated with the clinical features and survival rate of patients with intrahepatic cholangiocarcinoma. Clin Res Hepatol Gastroenterol. 2016;40:682\u20137.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"9881_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1475-2867-13-99","volume":"13","author":"RQ Liu","year":"2013","unstructured":"Liu RQ, Shen SJ, Hu XF, Liu J, Chen LJ, Li XY. Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognostic factors. Cancer Cell Int. 2013;13:99.","journal-title":"Cancer Cell Int"},{"key":"9881_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/jvh.12005","volume":"20","author":"ZF Wu","year":"2013","unstructured":"Wu ZF, Yang N, Li DY, Zhang HB, Yang GS. Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours. J Viral Hepat. 2013;20:306\u201310.","journal-title":"J Viral Hepat"},{"key":"9881_CR11","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1245\/s10434-010-1458-5","volume":"18","author":"NF Peng","year":"2011","unstructured":"Peng NF, Li LQ, Qin X, et al. Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus. Ann Surg Oncol. 2011;18:1258\u201366.","journal-title":"Ann Surg Oncol"},{"key":"9881_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/jso.21488","volume":"101","author":"L Zhang","year":"2010","unstructured":"Zhang L, Cai JQ, Zhao JJ, et al. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol. 2010;101:233\u20138.","journal-title":"J Surg Oncol"},{"key":"9881_CR13","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/hep.29413","volume":"66","author":"J Gu","year":"2017","unstructured":"Gu J, Jeong S, Xia Q. Intrahepatic cholangiocarcinoma arising from HBV infection may be a highly selected population for liver transplantation. Hepatology. 2017;66:1703\u20134.","journal-title":"Hepatology"},{"key":"9881_CR14","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3748\/wjg.v22.i10.3038","volume":"22","author":"Z Wang","year":"2016","unstructured":"Wang Z, Sheng YY, Dong QZ, Qin LX. Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: a meta-analysis. World J Gastroenterol. 2016;22:3038\u201351.","journal-title":"World J Gastroenterol"},{"key":"9881_CR15","doi-asserted-by":"publisher","first-page":"iii","DOI":"10.3310\/hta7270","volume":"7","author":"JJ Deeks","year":"2003","unstructured":"Deeks JJ, Dinnes J, D\u2019Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7:iii\u2013x (1\u2013173).","journal-title":"Health Technol Assess"},{"key":"9881_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"9881_CR17","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s00268-016-3843-0","volume":"41","author":"H Iida","year":"2017","unstructured":"Iida H, Kaibori M, Tanaka S, et al. Low incidence of lymph node metastasis after resection of hepatitis virus-related intrahepatic cholangiocarcinoma. World J Surg. 2017;41:1082\u20138.","journal-title":"World J Surg"},{"key":"9881_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3892\/mmr.2014.2689","volume":"11","author":"Y Lu","year":"2015","unstructured":"Lu Y, Lin N, Chen Z, Xu R. Hypoxia-induced secretion of platelet-derived growth factor-BB by hepatocellular carcinoma cells increases activated hepatic stellate cell proliferation, migration and expression of vascular endothelial growth factor-A. Mol Med Rep. 2015;11:691\u20137.","journal-title":"Mol Med Rep"},{"key":"9881_CR19","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245\u201355.","journal-title":"Lancet"},{"key":"9881_CR20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ajg.2009.674","volume":"105","author":"A Thelen","year":"2010","unstructured":"Thelen A, Scholz A, Weichert W, et al. Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma. Am J Gastroenterol. 2010;105:1123\u201332.","journal-title":"Am J Gastroenterol"},{"key":"9881_CR21","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.7150\/ijbs.21149","volume":"13","author":"S Jeong","year":"2017","unstructured":"Jeong S, Zheng B, Wang J, et al. Transarterial chemoembolization: a favorable postoperative management to improve prognosis of hepatitis B virus-associated intrahepatic cholangiocarcinoma after surgical resection. Int J Biol Sci. 2017;13:1234\u201341.","journal-title":"Int J Biol Sci"},{"key":"9881_CR22","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268\u201389.","journal-title":"J Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-018-9881-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-018-9881-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-018-9881-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T09:01:22Z","timestamp":1604480482000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-018-9881-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["9881"],"URL":"https:\/\/doi.org\/10.1007\/s12072-018-9881-y","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,26]]},"assertion":[{"value":"20 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Seogsong Jeong, Guijuan Luo, Zhi-Heng Wang, Meng Sha, Lei Chen and Qiang Xia declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}